Renal physiology and pathophysiology in pregnancy

Renal and Electrolyte Disorders: Seventh Edition

Volumn , Issue , 2012, Pages 462-518

  Jeyabalan, Arun ^a   Conrad, Kirk P ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974602933     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (398)

1. Conrad K. Renal changes in pregnancy. Urol Ann. 1992;6:313-340.
2. Cietak KA, Newton JR. Serial quantitative maternal nephrosonography in pregnancy. Br J Radiol. 1985;58(689):405-413.
3. Lindheimer MD, Conrad KP, Karamanchi AS. Renal physiology and disease in pregnancy. In: Alpern RJ, Hebert SC, eds. Seldin and Giebisch's The Kidney Physiology and Pathophysiology. 4th ed. New York: Elsevier; 2007.
4. Dure-Smith P. Pregnancy dilation of the urinary tract. Am J Obstet Gynecol. 1979;135:1066.
5. Cietak KA, Newton JR. Serial qualitative maternal nephrosonography in pregnancy. Br J Radiol. 1985;58(689):399-404.
6. Sims EA, Krantz KE. Serial studies of renal function during pregnancy and the puerperium in normal women. J Clin Invest. 1958;37(12): 1764-1774.
7. De Alvarez RR. Renal glomerulotubular mechanisms during normal pregnancy. I. Glomerular filtration rate, renal plasma flow, and creatinine clearance. Am J Obstet Gynecol. 1958;75(5): 931-944.
8. Assali NS, Dignam WJ, Dasgupta K. Renal function in human pregnancy. II. Effects of venous pooling on renal hemodynamics and water, electrolyte, and aldosterone excretion during gestation. J Lab Clin Med. 1959;54:394-408.
9. Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. Br J Obstet Gynaecol. 1981;88:1-9.
10. Roberts M, Lindheimer MD, Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol. 1996;270(2 pt 2): F338-F343.
11. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54(6):2056-2063.
12. Conrad KP. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Invest. 2004;11(7):438-448.
13. Davison JM, Noble MC. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol. 1981;88(1):10-17.
14. Conrad KP, Gaber LW, Lindheimer MD. The kidney in normal pregnancy and preeclampsia. In: Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego, CA: Elsevier; 2009:297-333.
15. Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int. 1985;27(1):74-79.
16. Davison JM. Changes in renal function in early pregnancy in women with one kidney. Yale J Biol Med. 1978;51(3):347-349.
17. Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989; 256(4 pt 2):H1060-H1065.
18. Slangen BF, Out IC, Verkeste CM, et al. Hemodynamic changes in early pregnancy in chronically instrumented, conscious rats. Am J Physiol. 1996;270(5 pt 2):H1779-H1784.
19. Gilson GJ, Mosher MD, Conrad KP. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am J Physiol. 1992;263(6 pt 2): H1911-H1918.
20. Baylis C. The mechanism of the increase in glomerular filtration rate in the twelve-day pregnant rat. J Physiol. 1980;305:405-414.
21. Milne JE, Lindheimer MD, Davison JM. Glomerular heteroporous membrane modeling in third trimester and postpartum before and during amino acid infusion. Am J Physiol Renal Physiol. 2002;282(1):F170-F175.
22. Chapman AB, Zamudio S, Woodmansee W, et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol. 1997;273(5 pt 2): F777-F782.
23. Sherwood OD. Relaxin. In: Knobil E, Neill JD, Greenwald GS, et al., eds. The Physiology of Reproduction. New York: Raven; 1994:861-1009.
24. Jeyabalan A, Shroff SG, Novak J, et al. The vascular actions of relaxin. Adv Exp Med Biol. 2007;612:65-87.
25. Novak J, Danielson LA, Kerchner LJ, et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest. 2001; 107(11):1469-1475.
26. Debrah DO, Novak J, Matthews JE, et al. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology. 2006;147(11):5126-5131.
27. Smith MC, Murdoch AP, Danielson LA, et al. Relaxin has a role in establishing a renal response in pregnancy. Fertil Steril. 2006;86(1): 253-255.
28. Debrah JE, Agoulnik A, Conrad KP. Changes in arterial function by chronic relaxin infusion are mediated by the leucine rich repeat G coupled Lgr7 receptor. Reprod Sci. 2008;15(1 suppl.): 217A.
29. McGuane JT, Debrah JE, Debrah DO, et al. Role of relaxin in maternal systemic and renal vascular adaptations during gestation. Ann N Y Acad Sci. 2009;1160:304-312.
30. Novak J, Rubin JP, Matthews J, et al. Relaxin (Rlx) mediated fast relaxation of arteries through P13 kinase and nitric oxide. FASEB J. 2007;21:A1371.
31. Matthews JE, Rubin JP, Novak J, et al. Vascular endothelial growth factor (VEGF) is a new player in the slow relaxin (Rlx) vasodilatory pathway. Reprod Sci. 2007;14(1 suppl.): 114A.
32. Debrah JE, McGuane JT, Novak J, et al. Vascular Endothelial and Placental Growth Factors: New Players in the Slow Relaxin Vasodilatory Pathway. 5th International Conference on Relaxin and Related Peptides. Hawaii; 2008.
33. Jeyabalan A, Novak J, Danielson LA, et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res. 2003;93(12): 1249-1257.
34. Jeyabalan A, Novak J, Doty KD, et al. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin. Endocrinology. 2007;148(1):189-197.
35. Conrad KP, Gandley RE, Ogawa T, et al. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Am J Physiol. 1999;276(5 pt 2): F767-F776.
36. Gandley RE, Conrad KP, McLaughlin MK. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol. 2001;280(1): R1-R7.
37. Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest. 1995;96(1):482-490.
38. Danielson LA, Conrad KP. Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats. Circ Res. 1996;79(6): 1161-1166.
39. Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52(11): 2682-2689.
40. Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. J Clin Invest. 1986;77(1):236-245.
41. Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest. 1999;103(4):525-533.
42. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272(2 pt 2): R441-R463.
43. Baylis C, Davison JM. Renal physiology in normal pregnancy. In: Feehally J, Floege J, Johnson RJ, eds. Comprehensive Clinical Nephrology. St. Louis, MI: Mosby Inc.; 2004:475-481.
44. Moe OW, Berry CA, Rector FC Jr. Renal transport of glucose, amino acids, sodium, chloride, and water. In: Brenner BM, ed. Brenner & Rector's The Kidney. 6th ed. Philadelphia, PA: WB Saunders Company; 2000.
45. Bishop JH, Green R. Glucose handling by distal portions of the nephron during pregnancy in the rat. J Physiol. 1983;336:131-142.
46. Davison JM. Renal nutrient excretion with emphasis on glucose. Clin Obstet Gynecol. 1975;2:365.
47. Davison JM. The excretion of glucose during normal pregnancy and after delivery. J Obstet Gynaecol Br Commonw. 1974;81:30-34.
48. Lind T, Hytten FE. The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw. 1972;79:961-965.
49. Davison JM, Hytten FE. The effect of pregnancy on the renal handling of glucose. Br J Obstet Gynaecol. 1975;82(5):374-381.
50. Christensen PJ. Tubular reabsorption of glucose during pregnancy. Scand J Clin Lab Invest. 1958;10(4):364-371.
51. Welsh GW 3rd, Sims EA. The mechanisms of renal glucosuria in pregnancy. Diabetes. 1960;9:363-369.
52. Davison JM, Sprott MS, Selkon JB. The effect of covert bacteriuria in schoolgirls on renal function at 18 years and during pregnancy. Lancet. 1984;2(8404):651-655.
53. Hytten FE, Cheyne GA. The aminoaciduria of pregnancy. J Obstet Gynaecol Br Commonw. 1972;79(5):424-432.
54. Sica DA, Schoolwerth AC. Renal handling of organic anions and cations: Excretion of uric acid. In: Brenner BM, ed. Brenner & Rector's The Kidney. 6th ed. Philadelphia, PA: WB Saunders Company; 2000.
55. Boyle JA, Campbell S, Duncan AM, et al. Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol. 1966;19(5):501-503.
56. Dunlop W, Davison JM. The effect of normal pregnancy upon the renal handling of uric acid. Br J Obstet Gynaecol. 1977;84(1):13-21.
57. Lind T, Godfrey KA, Otun H, et al. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol. 1984;91(2):128-132.
58. Semple PF, Carswell W, Boyle JA. Serial studies of the renal clearance of urate and insulin during pregnancy and after the puerperium in normal women. Clin Sci Mol Med. 1974;47(6):559-565.
59. Suki WN, Lederer ED, Rouse D. Renal transport of calcium, magnesium, and phosphate. In: Brenner BM, ed. Brenner & Rector's The Kidney. 6th ed. Philadelphia, PA: WB Saunders Company; 2000.
60. Gertner JM, Coustan DR, Kliger AS, et al. Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med. 1986;81:451-456.
61. Howarth AT, Morgan DB, Payne RB. Urinary excretion of calcium in late pregnancy and its relation to creatinine clearance. Am J Obstet Gynecol. 1977;129(5):499-502.
62. Maikranz P, Holley JL, Parks JH, et al. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989;36(1): 108-113.
63. Pedersen EB, Johannesen P, Kristensen S, et al. Calcium, parathyroid hormone and calcitonin in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 1984;18(3):156-164.
64. Pitkin RM. Calcium metabolism in pregnancy and the perinatal period: A review. Am J Obstet Gynecol. 1985;151(1):99-109.
65. Davis OK, Hawkins DS, Rubin LP, et al. Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab. 1988;67(4): 850-852.
66. Seki K, Makimura N, Mitsui C, et al. Calcium-regulating hormones and osteocalcin levels during pregnancy: A longitudinal study. Am J Obstet Gynecol. 1991;164(5 pt 1):1248-1252.
67. Whitehead M, Lane G, Young O, et al. Interrelations of calcium-regulating hormones during normal pregnancy. Br Med J (Clin Res Ed). 1981;283(6283):10-12.
68. Kumar R, Cohen WR, Silva P, et al. Elevated 1, 25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest. 1979;63(2):342-344.
69. Paulson SK, DeLuca HF. Vitamin D metabolism during pregnancy. Bone. 1986;7(5):331-336.
70. Weisman Y, Harell A, Edelstein S, et al. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature. 1979;281(5729):317-319.
71. Marya RK, Rathee S, Manrow M. Urinary calcium excretion in pregnancy. Gynecol Obstet Invest. 1987;23(2):141-144.
72. Wabner C, Sirivongs D, Maikranz P, et al. Evidence for increased excretion in pregnancy of nephrocalcin, a urinary inhibitor of calcium oxalate crystal growth. Kidney Int. 1987;31:359.
73. Lindheimer MD, Richardson DA, Ehrlich EN, et al. Potassium homeostasis in pregnancy. J Reprod Med. 1987;32(7):517-522.
74. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289(5476):119-123.
75. Bayliss DA, Millhorn DE, Gallman EA, et al. Progesterone stimulates respiration through a central nervous system steroid receptor-mediated mechanism in cat. Proc Natl Acad Sci U S A. 1987;84(21):7788-7792.
76. Weinberger SE, Weiss ST, Cohen WR, et al. Pregnancy and the lung. Am Rev Respir Dis. 1980;121(3):559-581.
77. Lim VS, Katz AI, Lindheimer MD. Acid-base regulation in pregnancy. Am J Physiol. 1976;231(6):1764-1769.
78. Lindheimer MD, Davison JM. Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol. 1995;132(2):133-143.
79. Davison JM, Shiells EA, Philips PR, et al. Influence of humoral and volume factors on altered osmoregulation of normal human pregnancy. Am J Physiol. 1990;258(4 pt 2):F900-F907.
80. Danielson LA, Kercher LJ, Conrad KP. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol. 2000;279(4):R1298-R1304.
81. Weisinger RS, Burns P, Eddie LW, et al. Relaxin alters the plasma osmolality-arginine vasopressin relationship in the rat. J Endocrinol. 1993;137(3): 505-510.
82. Danielson LE, Debrah JE, Conrad KP. The role of human chorionic gonadotropin in maternal vasodilation of pregnancy. Reprod Sci. 2008;15 (1 suppl.):218A.
83. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev. 2004;25(2): 205-234.
84. Bell RJ, Laurence BM, Meehan PJ, et al. Regulation and function of arginine vasopressin in pregnant sheep. Am J Physiol. 1986; 250(5 pt 2):F777-F780.
85. Barron WM, Durr JA, Schrier RW, et al. Role of hemodynamic factors in osmoregulatory alterations of rat pregnancy. Am J Physiol. 1989; 257 (4 pt 2):R909-R916.
86. Barron WM, Stamoutsos BA, Lindheimer MD. Role of volume in the regulation of vasopressin secretion during pregnancy in the rat. J Clin Invest. 1984;73(4):923-932.
87. Silvertown JD, Fraser R, Poterski RS, et al. Central effects of long-term relaxin expression in the rat. Ann N Y Acad Sci. 2005;1041:216-222.
88. Ohara M, Martin PY, Xu DL, et al. Upregulation of aquaporin 2 water channel expression in pregnant rats. J Clin Invest. 1998;101(5): 1076-1083.
89. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med. 1988;16:1065-1072.
90. Spaanderman ME, Meertens M, van Bussel M, et al. Cardiac output increases independently of basal metabolic rate in early human pregnancy. Am J Physiol Heart Circ Physiol. 2000;278(5): H1585-H1588.
91. Phippard AF, Horvath JS, Glynn EM, et al. Circulatory adaptation to pregnancy-serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hyper-tens. 1986;4(6):773-779.
92. Chesley LC, Valenti C, Rein H. Excretion of sodium loads by nonpregnant and pregnant normal, hypertensive and pre-eclamptic women. Metabolism. 1958;7(5):575-588.
93. Brown MA, Gallery ED, Ross MR, et al. Sodium excretion in normal and hypertensive pregnancy: A prospective study. Am J Obstet Gynecol. 1988; 159(2):297-307.
94. Baylis C, Blantz RC. Tubuloglomerular feedback activity in virgin and 12-day-pregnant rats. Am J Physiol. 1985;249(1 pt 2):F169-F173.
95. Ni XP, Safai M, Rishi R, et al. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat. J Am Soc Nephrol. 2004;15(5):1254-1260.
96. Knight S, Snellen H, Humphreys M, et al. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. Am J Physiol Renal Physiol. 2007;292(2):F655-F659.
97. Irons DW, Baylis PH, Davison JM. Effect of atrial natriuretic peptide on renal hemodynamics and sodium excretion during human pregnancy. Am J Physiol. 1996;271(1 pt 2):F239-F242.
98. Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NO (x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol. 1999; 277(1 pt 2):F48-F57.
99. Khraibi AA, Haas JA, Knox FG. Effect of renal perfusion pressure on renal interstitial hydrostatic pressure in rats. Am J Physiol. 1989;256(1 pt 2): F165-F170.
100. Garcia-Estan J, Roman RJ. Role of renal interstitial hydrostatic pressure in the pressure diuresis response. Am J Physiol. 1989;256(1 pt 2): F63-F70.
101. Khraibi AA. Renal interstitial hydrostatic pressure and pressure natriuresis in pregnant rats. Am J Physiol Renal Physiol. 2000;279(2):F353-F357.
102. Khraibi AA, Dobrian AD, Yu T, et al. Role of RIHP and renal tubular sodium transporters in volume retention of pregnant rats. Am J Hypertens. 2005; 18(10):1375-1383.
103. Samuel CS, Lekgabe ED, Mookerjee I. The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease. Adv Exp Med Biol. 2007;612:88-103.
104. Gifford RW, August PA, Cunningham FG, et al. Report of the National High Blood Pressure Working Group on research on hypertension in pregnancy. Am J Obstet Gynecol. 2000;183: S1-S22.
105. Lindheimer MD, Roberts JM, Cunningham FG, et al. Introduction, history, controversies, and definitions. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego, CA: Elsevier; 2009:1-24.
106. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean (see comment). Br J Obstet Gynaecol. 1992;99(7):547-553.
107. Tang LC, Kwok AC, Wong AY, et al. Critical care in obstetrical patients: An eight-year review. Chin Med J. 1997;110(12):936-941.
108. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339(5):313-320.
109. Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200-1204.
110. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol. 1991;15(1):86-93.
111. Woelkers DA, Roberts JM. The endothelium and pre-eclampsia. In: Rubin PC, ed. Handbook of Hypertension. New York: Elsevier; 2000:126-162.
112. Lindheimer M, Roberts J, Cunningham F, et al. Introduction, history, controversies, and definitions. In: Lindheimer M, Roberts J, Cunningham F, eds. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Stamford, CN: Appleton and Lange; 1999:3-41.
113. North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pre-eclampsia. Br J Obstet Gynaecol. 1999;106(8):767-773.
114. Zhang J, Klebanoff MA, Roberts JM. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet Gynecol. 2001; 97(2):261-267.
115. Thomson AM, Hytten FE, Billewicz WZ. The epidemiology of oedema during pregnancy. J Obstet Gynaecol Br Commonw. 1967;74(1):1-10.
116. American College of Obstetricians and Gynecologists (ACOG). Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin no 33, January 2002. Obstet Gynecol. 2002;99:159-167.
117. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol. 1999;42(2):381-389.
118. Ness RB, Roberts JM. Epidemiology of pregnancy-related hypertension. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego,CA: Elsevier; 2009:37.S-50.S
119. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339(10): 667-671.
120. Hanson U, Persson B. Outcome of pregnancies complicated by type 1 insulin-dependent diabetes in Sweden: Acute pregnancy complications, neonatal mortality and morbidity. Am J Perinatol. 1993;10(4):330-333.
121. Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182(2): 364-369.
122. Day MC, Barton JR, O'Brien JM, et al. The effect of fetal number on the development of hypertensive conditions of pregnancy. Obstet Gynecol. 2005;106(5 pt 1):927-931.
123. England L, Zhang J. Smoking and risk of preeclampsia: A systematic review. Front Biosci. 2007;12:2471-2483.
124. Conde-Agudelo A, Althabe F, Belizan JM, et al. Cigarette smoking during pregnancy and risk of preeclampsia: A systematic review. Am J Obstet Gynecol. 1999;181(4):1026-1035.
125. Jeyabalan A, Powers RW, Durica AR, et al. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008;21(8):943-947.
126. Mehendale R, Hibbard J, Fazleabas A, et al. Placental angiogenesis markers sFlt-1 and PlGF: Response to cigarette smoke. Am J Obstet Gynecol. 2007;197(4):363.e1-e5.
127. Sibai BM, Cunningham FG. Prevention of preeclampsia and eclampsia. In: Lindheimer M, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego, CA: Elsevier (Academic Press); 2009:213-226.
128. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: A meta-analysis of randomized controlled trials. JAMA. 1996; 275(14):1113-1117.
129. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med. 1997;337(2):69-76.
130. Villar J, Belizan JM. Same nutrient, different hypotheses: Disparities in trials of calcium supplementation during pregnancy. Am J Clin Nutr. 2000;71(5 suppl.):1375S-1379S.
131. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006;194(3): 639-649.
132. Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems Cochrane Database Syst Rev. 2005;(4). (Update in Cochrane Database Syst Rev. 2006;3:CD001059; PMID:16855957. 2005).
133. Beaufils M, Uzan S, Donsimoni R, et al. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985;1(8433):840-842.
134. Schiff E, Peleg E, Goldenberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 1989;321(6):351-356.
135. Hauth JC, Goldenberg RL, Parker CR Jr, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol. 1993;168(4): 1083-1091.
136. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 1998;338(11):701-705.
137. Anonymous. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.Lancet. 1994;343(8898):619-629.
138. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1993;329(17):1213-1218.
139. Subtil D, Goeusse P, Puech F, et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: The Essai Regional Aspirine Mere-Enfant study (Part 1). Br J Obstet Gynaecol.2003;110(5):475-484.
140. Coomarasamy A, Honest H, Papaioannou S, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: A systematic review. Obstet Gynecol. 2003;101(6):1319-1332.
141. Duley L, Henderson-Smart DJ, Knight M, et al. Antiplatelet agents for preventing pre-eclampsia and its complications (systematic review). Cochrane Database Syst Rev. 2005;(4).
142. Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet. 2007;369(9575):1791-1798.
143. Bilodeau JF, Hubel CA. Current concepts in the use of antioxidants for the treatment of preeclampsia. J Obstet Gynaecol Can. 2003;25(9): 742-750.
144. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomised trial. Lancet. 1999;354(9181):810-816.
145. Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Lancet. 2006;367(9517): 1145-1154.
146. Rumbold AR, Crowther CA, Haslam RR, et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006;354(17):1796-1806.
147. Spinnato JAIIMD, Freire SMD, Pinto e Silva JLMD, et al. Antioxidant therapy to prevent preeclampsia: A randomized controlled trial. Obstet Gynecol. 2007;110(6):1311-1318.
148. Roberts JM, for the Eunice Kennedy Shriver NIoCHaHDMN. A randomized controlled trial of antioxidant vitamins to prevent serious complications associated with pregnancy related hypertension in low risk, nulliparous women. Am J Obstet Gynecol. 2009;199(6A):S8.
149. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: Patient selection, treatment, and delivery indications. Am J Obstet Gynecol. 2007;196:514.e1-e9.
150. Roberts JM, Bodnar LM, Lain KY, et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46(6):1263-1269.
151. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet. 2002;359(9321):1877-1890.
152. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333(4):201-205.
153. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003(4):CD000128.
154. Anonymous. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345(8963): 1455-1463.
155. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia (systematic review). Cochrane Database Syst Rev. 2005;(4).
156. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after firsttrimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-2451.
157. Serreau R, Luton D, Macher MA, et al. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: A report of 10 cases. Br J Obstet Gynaecol. 2005; 112(6):710-712.
158. Sedman AB, Kershaw DB, Bunchman TE. Recognition and management of angiotensin converting enzyme inhibitor fetopathy. Pediatr Nephrol. 1995;9(3):382-385.
159. Chesley SC, Annitto JE, Cosgrove RA, et al. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol. 1976;124(5): 446-459.
160. Irgens HU, Reisaeter L, Irgens LM, et al. Long term mortality of mothers and fathers after preeclampsia: Population based cohort study. BMJ. 2001;323(7323):1213-1217.
161. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology. 2005;16(2):206-215.
162. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002-2006.
163. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165(5 pt 1):1408-1412.
164. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia eclampsia: A systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.
165. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800-809.
166. Brosens JJ, Pijnenborg R, Brosens IA. The myome-trial junctional zone spiral arteries in normal and abnormal pregnancies: A review of the literature. Am J Obstet Gynecol. 2002;187(5):1416-1423.
167. Burton GJ, Woods AW, Jauniaux E. The Effects of Physiological Conversion of the Spiral Arteries on Utero-Placental Blood Flow. Reprod Sci Suppl. 2009;16(3):95A.
168. Red-HorseK,RiveraJ,SchanzA,etal.Cytotrophoblastinductionofarterialapoptosisand lymphangiogenesisinaninvivomodelofhuman placentation.JClinInvest.2006;116(10):2643-2652.
169. Founds SA, Conley YP, Lyons-Weiler JF, et al. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009;30(1):15-24.
170. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol. 1939;37:291-293.
171. Rajakumar A, Jeyabalan A, Markovic N, et al. Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction. Am J Physiol. 2007;293(2):R766-R774.
172. Rajakumar A, Whitelock KA, Weissfeld LA, et al. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod. 2001;64(2):499-506.
173. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999;155(1):293-301.
174. Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol. 2007;76(1-2):61-67.
175. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 308(5728):1592-1594.
176. Gammill HS, Roberts JM. Emerging concepts in preeclampsia investigation. Front Biosci. 2007;12: 2403-2411.
177. Aardenburg R, Spaanderman ME, van Eijndhoven HW, et al. A low plasma volume in formerly preeclamptic women predisposes to the recurrence of hypertensive complications in the next pregnancy. J Soc Gynecol Invest. 2006;13(8): 598-603.
178. Fink GD. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. Hypertension. 2009;53(pt 2):307-312.
179. Rajakumar A, Brandon HM, Daftary A, et al. Evidence for the functional activity of hypoxiainducible transcription factors overexpressed in preeclamptic placentae. Placenta. 2004;25(10): 763-769.
180. Manyonda IT, Slater DM, Fenske C, et al. A role for noradrenaline in pre-eclampsia: Towards a unifying hypothesis for the pathophysiology. Br J Obstet Gynaecol. 1998;105(6):641-648.
181. Rajakumar A, Michael HM, Rajakumar PA, et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005;26(7):563-573.
182. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103(7):945-952.
183. Benyo DF, Smarason A, Redman CW, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86(6):2505-2512.
184. Chesley LC. False starts in the study of preeclampsia-eclampsia. Obstet Gynecol Annu. 1976;5:177-187.
185. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hyper-tension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658.
186. Lain KY, Wilson JW, Crombleholme WR, et al. Smoking during pregnancy is associated with alterations in markers of endothelial function. Am J Obstet Gynecol. 2003;189(4):1196-1201.
187. Eremina V, Sood M, Haigh J, et al. Glomerularspecific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 2003;111(5):707-716.
188. Yang JC, Haworth L, Sherry RM, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med. 2003;349(5):427-434.
189. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683.
190. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol. 2005;193(1):185-191.
191. Wallenburg HCS. Hemodynamics in hypertensive pregnancy. In: Rubin PC, ed. Handbook of Hyper-tension. New York: Elsevier Science Publishers; 1988:66-101.
192. Sibai BM, Mabie WC. Hemodynamics of preeclampsia. Clin Perinatol. 1991;18(4): 727-747.
193. Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 1991;17(6 pt 2):1072-1077.
194. Lang RM, Pridjian G, Feldman T, et al. Left ventricular mechanics in preeclampsia. Am Heart J. 1991;121(6 pt 1):1768-1775.
195. Easterling TR, Benedetti TJ, Schmucker BC, et al. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study. Obstet Gynecol. 1990;76(6):1061-1069.
196. Bosio PM, McKenna PJ, Conroy R, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;6:978-984.
197. Messerli FH, De Carvalho JG, Christie B, et al. Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation. 1978;58(3 pt 1): 441-448.
198. Hall JE. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994; 23(3):381-394.
199. Assali NS, Kaplan SA, Fomon SJ, et al. Renal function studies in toxemia of pregnancy; excretion of solutes and renal hemodynamics during osmotic diuresis in hydropenia. J Clin Invest. 1953;32(1):44-51.
200. McCartney CP, Spargo B, Lorincz AB, et al. Renal structure and function in pregnant patients with acute hypertension; osmolar concentration. Am J Obstet Gynecol. 1964;90:579-592.
201. Sarles HE, Hil SS, LeBlanc AL, et al. Sodium excretion patterns during and following intravenous sodium chloride loads in normal and hypertensive pregnancies. Am J Obstet Gynecol. 1968; 102(1):1-7.
202. Moran P, Lindheimer MD, Davison JM. The renal response to preeclampsia. Semin Nephrol. 2004; 24(6):588-595.
203. Pollak VE, Nettles JB. The kidney in toxemia of pregnancy: A clinical and pathologic study based on renal biopsies. Medicine (Baltimore). 1960;39: 469-526.
204. Redman CW, Beilin LJ, Bonnar J, et al. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet. 1976;1(7974): 1370-1373.
205. Redman CW, Beilin LJ, Bonnar J. Renal function in preeclampsia. J Clin Pathol Suppl (R Coll Pathol). 1976;10:91-94.
206. Sagen N, Haram K, Nilsen ST. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstet Gynecol Scand. 1984;63(1):71-75.
207. Hayashi TT. The effect of benemid on uric acid excretion in normal pregnancy and in preeclampsia. Am J Obstet Gynecol. 1957;73(1): 17-22.
208. Czaczkes WJ, Ullmann TD, Sadowsky E. Plasma uric acid levels, uric acid excretion, and response to probenecid in toxemia of pregnancy. J Lab Clin Med. 1958;51(2):224-229.
209. Fadel H, Osman L. Uterine-vein uric acid in EPHgestosis and normal pregnancy. Schweiz Z Gynak Geburtsh. 1970;1:395-398.
210. Hayashi TT, Gillo D, Robbins H, et al. Simultaneous measurement of plasma and erythrocyte oxypurines. I. Normal and toxemic pregnancy. Gynecol Invest. 1972;3(5):221-236.
211. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol. 1996;174(1 pt 1):288-291.
212. Redman CW. Maternal plasma volume and disorders of pregnancy. Br Med J (Clin Res Ed). 1984;288(6422):955-956.
213. Brown MA, Zammit VC, Mitar DM. Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens. 1992;10(1):61-68.
214. Taufield PA, Ales KL, Resnick LM, et al. Hypocalciuria in preeclampsia. N Engl J Med. 1987; 316(12):715-718.
215. Frenkel Y, Barkai G, Mashiach S, et al. Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Obstet Gynecol. 1991;77(5): 689-691.
216. Sanchez-Ramos L, Sandroni S, Andres FJ, et al. Calcium excretion in preeclampsia. Obstet Gynecol. 1991;77(4):510-513.
217. Seely EW, Wood RJ, Brown EM, et al. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab. 1992;74(6):1436-1440.
218. August P, Marcaccio B, Gertner JM, et al. Abnormal 1,25-dihydroxyvitamin D metabolism in preeclampsia. Am J Obstet Gynecol. 1992;166(4): 1295-1299.
219. Szmidt-Adjide V, Vendittelli F, David S, et al. Calciuria and preeclampsia: A case-control study. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):193-198.
220. Ingec M, Nazik H, Kadanali S. Urinary calcium excretion in severe preeclampsia and eclampsia. Clin Chem Lab Med. 2006;44(1):51-53.
221. Halhali A, Diaz L, Avila E, et al. Decreased fractional urinary calcium excretion and serum 1, 25-dihydroxyvitamin D and IGF-I levels in preeclampsia. J Steroid Biochem Mol Biol. 2006; 103:803-806.
222. Ohara N, Yamasaki M, Morikawa H, et al. Dynamics of calcium metabolism and calcium-regulating hormones in pregnancy-induced hypertension. Nippon Naibunpi Gakkai Zasshi. 1986;8:882-896.
223. Seely EW, Graves SW. Calcium homeostasis in normotensive and hypertensive pregnancy. Compr Ther. 1993;19(3):124-128.
224. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007;18(8):2281-2284.
225. Mayer A. Changes in the endothelium during eclampsia and their significance (translation from German). Klin Wochenzetschrift. 1924;H27.
226. Robson JS. Proteinuria and the renal lesion in preeclampsia and abruptio placentae. Perspect Nephrol Hypertens. 1976;5:61-73.
227. Lopez-Lera M, Rubio G. Severe abruption placentae, toxemia of pregnancy and renal biopsy. Am J Obstet Gynecol. 1965;93:1144-1150.
228. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 2003; 110(9):831-836.
229. Strevens H, Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. Br J Obstet Gynaecol. 2003;110(9): 825-830.
230. Wide-Swensson D, Strevens H, Willner J. Antepartum percutaneous renal biopsy. Int J Gynaecol Obstet. 2007;98(2):88-92.
231. Lu F, Longo M, Tamayo E, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007;196(4):396 e1-7; discussion e7.
232. Kincaid-Smith P. The renal lesion of preeclampsia revisited. Am J Kidney Dis. 1991;17:144-148.
233. Fadel HE, Sabour MS, Mahran M, et al. Reversibility of the renal lesion and functional impairment in preeclampsia diagnosed by renal biopsy. Obstet Gynecol. 1969;33(4):528-534.
234. Oe PL, Ooms EC, Uttendorfsky OT, et al. Post-partum resolution of glomerular changes in edema-proteinuria-hypertension gestosis. Ren Physiol. 1980;3(1-6):375-379.
235. Pollak VE, Pirani CL, Kark RM, et al. Reversible glomerular lesions in toxaemia of pregnancy. Lancet. 1956;271(6933):59-62.
236. August PA, Lindheimer M. Chronic hypertension and pregnancy. In: Lindheimer M, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. San Diego, CA: Elsevier ; 2009:353-368.
237. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2572.
238. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol. 1994;171(2):410-416.
239. Podymow T, August P. Update on the use of anti-hypertensive drugs in pregnancy. Hypertension. 2008;51(4):960-969.
240. Umans JG, Abalos EJ, Lindheimer MD. Antihypertensive treatment. In: Lindheimer MD, Roberts JM, Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy. 3rd ed. San Diego, CA: Elsevier; 2009:369-388.
241. Redman CW. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976; 2(7989):753-756.
242. Montan S, Anandakumar C, Arulkumaran S, et al. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol. 1993;168(1 pt 1): 152-156.
243. Houlihan DD, Dennedy MC, Ravikumar N, et al. Anti-hypertensive therapy and the feto-placental circulation: Effects on umbilical artery resistance. J Perinat Med. 2004;32(4):315-319.
244. Waterman EJ, Magee LA, Lim KI, et al. Do commonly used oral antihypertensives alter fetal or neonatal heart rate characteristics? A systematic review. Hypertens Pregnancy. 2004;23(2): 155-169.
245. Cockburn J, Moar VA, Ounsted M, et al. Final report of study on hypertension during pregnancy: The effects of specific treatment on the growth and development of the children. Lancet. 1982;1(8273):647-649.
246. Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96(1):38-43.
247. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301(6752):587-589.
248. Gazzolo D, Visser GH, Santi F, et al. Behavioural development and Doppler velocimetry in relation to perinatal outcome in small for dates fetuses. Early Hum Dev. 1995;43(2):185-195.
249. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol. 1993;100:959-961.
250. Grossman E, Messerli FH, Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? (see comment). JAMA. (Review). 1996;276(16):1328-1331.
251. Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study. Am J Obstet Gynecol. 1996;174(3):823-828.
252. Little PJ. The incidence of urinary tract infection in 5000 pregnant women. Lancet. 1966;2: 925-928.
253. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women (see comment). N Engl J Med. 2000;343(14):992-997.
254. Sheffield JS, Cunningham FG. Urinary tract infection in women. Obstet Gynecol. 2005;106(5): 1085-1092.
255. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2001(2):CD000490.
256. Nicolle Lindsay ÂE, Bradley S, Colgan R, et al. Infectious diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clin Infect Dis. 2005;40(5): 643-654.
257. Millar L, DeBuque L, Leialoha C, et al. Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstet Gynecol. 2000;95(4): 601-604.
258. McNair RD, MacDonald SR, Dooley SL, et al. Evaluation of the centrifuged and Gram-stained smear, urinalysis, and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. Am J Obstet Gynecol. 2000;182(5): 1076-1079.
259. Shelton SD, Boggess KA, Kirvan K, et al. Urinary interleukin-8 with asymptomatic bacteriuria in pregnancy. Obstet Gynecol. 2001;97(4):583-586.
260. Ben David S, Einarson T, Ben David Y, et al. The safety of nitrofurantoin during the first trimester of pregnancy: Meta-analysis. Fundam Clin Pharmacol. 1995;9(5):503-507.
261. Williams DJ, Davison JM. Renal Disorders. In: Creasy RK, Resnik R, Iams JD, et al., eds. Creasy and Resnik's Maternal-Fetal Medicine Principles and Practice. 6th ed. Philadelphia, PA: Elsevier; 2009:905-926.
262. Vercaigne LM, Zhanel GG. Recommended treatment for urinary tract infection in pregnancy. Ann Pharmacother. 1994;28(2):248-251.
263. Tan JS, File TM Jr. Treatment of bacteriuria in pregnancy. Drugs. 1992;44(6):972-980.
264. Patterson TF, Andriole VT, Patterson TF, et al. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am. 1997;11(3): 593-608.
265. Hill JB, Sheffield JS, McIntire DD, et al. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105(1):18-23.
266. Petersson C, Hedges S, Stenqvist K, et al. Suppressed antibody and interleukin-6 responses to acute pyelonephritis in pregnancy. Kidney Int. 1994;45(2):571-577.
267. Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol. 1994;8(2):353-373.
268. Cunningham FG, Lucas MJ, Hankins GD, et al. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol. 1987;156(4) : 797-807.
269. Towers CV, Kaminskas CM, Garite TJ, et al. Pulmonary injury associated with antepartum pyelonephritis: Can patients at risk be identified? Am J Obstet Gynecol. 1991;164(4):974-978.
270. Millar LK, DeBuque L, Wing DA. Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth. J Perinat Med. 2003;31(1): 41-46.
271. Lang JM, Lieberman E, Cohen A. A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology. 1996;7(4): 369-376.
272. Wing DA, Park AS, Debuque L, et al. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol. 2000;182(6): 1437-1440.
273. Wing DA, Hendershott CM, Debuque L, et al. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol. 1998;92(2):249-253.
274. Wing DA, Hendershott CM, Debuque L, et al. Outpatient treatment of acute pyelonephritis in pregnancy after 24 weeks. Obstet Gynecol. 1999;94(5 pt 1):683-688.
275. Millar LK, Wing DA, Paul RH, et al. Outpatient treatment of pyelonephritis in pregnancy: A randomized controlled trial. Obstet Gynecol. 1995;86(4 pt 1):560-564.
276. Stratta P, Canavese C, Dogliani M, et al. Pregnancy-related acute renal failure. Clin Nephrol. 1989; 32(1):14-20.
277. Turney J, Ellis C, Parsons F. Obsteric acute renal failure 1956-1987. Br J Obstet Gynaecol. 1989;96: 679-687.
278. Grunfeld J, Pertuiset N. Acute renal failure in pregnancy: 1987. Am J Kidney Dis. 1987;9(4): 359-362.
279. Stratta P, Besso L, Canavese C, et al. Is pregnancy-related acute renal failure a disappearing clinical entity? Ren Fail. 1996;18(4):575-584.
280. Alexopoulos E, Tambakoudis P, Bili H, et al. Acute renal failure in pregnancy. Ren Fail. 1993;15(5):609-613.
281. Chugh K, Singhal P, Sharma B. Acute renal failure of obstetric origin. Obstet Gynecol. 1976;48: 642-646.
282. Prakash J, Tripatti K, Srivastava P. Pregnancy related acute renal failure is still high in India. In: Proceedings of the 11th International Congress of Nephrologists. 1990:15A.
283. Nzerue C, Hewan-Lowe K, Nwawka C. Acute renal failure in pregnancy: A review of clinical outcomes at an inner-city hospital from 1986-1996. J Natl Med Assoc. 1998;90:486-490.
284. Thadhani R, Pascual M, Bonventre J. Acute renal failure. N Engl J Med. 1996;334(22): 1448-1460.
285. Bouman C, Kellum J, Lamiere N, et al. Definition for acute renal failure. 2003 (updated 2003; cited); Available from: www.adqi.net.
286. Asrat T, Nageotte M. Acute renal failure in pregnancy. In: Foley, ed. Obstetric Intensive Care Manual. 2nd ed: McGraw-Hill; 2004:184-195.
287. Gammill HS, Jeyabalan A. Acute renal failure in pregnancy. Crit Care Med. 2005;33(10 suppl.): S372-S384.
288. Bellomo R. Defining, quantifying, and classifying acute renal failure. Crit Care Clin. 2005;21: 223-237.
289. Parrish A. Complications of percutaneous renal biopsy: A review of 37 years' experience. Clin Nephrol. 1992;38:135-141.
290. Dennis EJ, McIver FA, Smythe CM. Renal biopsy in pregnancy. Clin Obstet Gynecol. 1968;11(2): 473-486.
291. Schewitz L, Friedman I, Pollack V. Bleeding after renal biosy in pregnancy. Obstet Gynecol. 1965;26: 295-304.
292. Packham D, Fairley KF. Renal biopsy: Indications and complications in pregnancy. Br J Obstet Gynaecol. 1987;94(10):935-939.
293. Lindheimer MD, Davison JM. Renal biopsy during pregnancy: 'To b . . . or not to b . . .?'. Br J Obstet Gynaecol. 1987;94(10):932-934.
294. Kuller JA, D'Andrea NM, McMahon MJ. Renal biopsy and pregnancy. Am J Obstet Gynecol. 2001;184(6):1093-1096.
295. Chen HH, Lin HC, Yeh JC, et al. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet Gynecol Scand. 2001;80(10): 888-893.
296. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Lancet. 2000;356(9248):2139-2143.
297. Marik PE. Low-dose dopamine: A systematic review [review and 68 references]. Intensive Care Med. 2002;28(7):877-883.
298. Kellum JAMDM, Decker JRN. Use of dopamine in acute renal failure: A meta-analysis (Article). Critical Care Med. 2001;29(8):1526-1531.
299. Bagshaw SM, Delaney A, Haase M, et al. Loop diuretics in the management of acute renal failure: A systematic review and meta-analysis. Critical Care Resusc. 2007;9(1):60-68.
300. Venkataraman R, Kellum JA. Prevention of acute renal failure. Chest. 2007;131(1):300-308.
301. Pertuiset N, Grunfeld JP. Acute renal failure in pregnancy [review and 86 references]. Baillieres Clin Obstet Gynaecol. 1994;8(2):333-351.
302. Drakeley AJ, Le Roux PA, Anthony J, et al. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol. 2002;186(2): 253-256.
303. Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertensive disorders of pregnancy. Pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol. 1990;162(3):777-783.
304. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol. 1993;168(6 pt 1):1682-1690.
305. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases (see comment). Am J Obstet Gynecol. 1999;181(2):389-395.
306. Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: An experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994;171(5):1342-1347.
307. Riely CA. Acute fatty liver of pregnancy. Semin Liver Dis. 1987;7(1):47-54.
308. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340(22):1723-1731.
309. Abenhaim HA, Azoulay L, Kramer MS, et al. Incidence and risk factors of amniotic fluid embolisms: A population-based study on 3 million births in the United States. [see comment]. Am J Obstet Gynecol. 2008;199(1):49.e1-e8.
310. Clark SL, Hankins GD, Dudley DA, et al. Amniotic fluid embolism: Analysis of the national registry (see comment). Am J Obstet Gynecol. 1995;172(4 pt 1):1158-1167.
311. Dashe JS, Ramin SM, Cunningham FG. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol. 1998;91(5 pt 1):662-668.
312. Esplin MSM, Branch DW. Diagnosis and management of thrombotic microangiopathies during pregnancy (article). Clin Obstet Gynecol Ambul Gynecol. 1999;42(2):360-367.
313. Elliott MAMD, Nichols WLMD. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (review). Mayo Clinic Proc. 2001;76(11):1154-1162.
314. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998;339(22): 1578-1584.
315. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-1594.
316. George JN. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2003; 10(5):339-344.
317. Weiner C. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol. 1987;24:119-129.
318. Egerman RSMD, Witlin AGDO, Friedman SAMD, et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: Review of 11 cases (abstract). Am J Obstet Gynecol. 1996;175(4):950-956.
319. Francois KE, Foley MR. Antepartum and postpartum hemorrhage. In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics Normal and Problem Pregnancies. 5th ed. Philadelphia, PA: Elsevier; 2007:456-485.
320. Klebanoff MA, Koslowe PA, Kaslow R, et al. Epidemiology of vomiting in early pregnancy. Obstet Gynecol. 1985;66(5):612-616.
321. Hill JB, Yost NP, Wendel GD Jr. Acute renal failure in association with severe hyperemesis gravidarum. Obstet Gynecol. 2002;100(5 pt 2): 1119-1121.
322. Robson J, Martin A, Ruckley V, et al. Irreversible postpartum renal failure. Q J Med. 1968;37: 423-435.
323. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993;36(4): 795-808.
324. Sweet R, Gibbs R. Intraamniotic Infection. In: Sweet R, ed. Infectious Diseases of the Female Genital Tract. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2002:516-527.
325. LaPata R, McElin T, Adelson B. Ureteral obstruction due to compression by the gravid uterus. Am J Obstet Gynecol. 1970;106(6):941-942.
326. Courban D, Blank S, Harris M, et al. Acute renal failure in the first trimester resulting from uterine leiomyomas. Am J Obstet Gynecol. 1997;177: 472-473.
327. Seeds J, Cefalo R, Herbert W, et al. Hydramnios and maternal renal failure: Relief with fetal therapy. Obstet Gynecol. 1984;64(3 suppl.): 26S-29S.
328. Vintzileos A, Turner G, Campbell W, et al. Polyhydramnios and obstructive renal failure: A case report and review of the literature. Am J Obstet Gynecol. 1985;152(7):883-885.
329. Brandes J, Fritsche C. Obstructive acute renal failure by a gravid uterus: A case report and review. Am J Kidney Dis. 1991;18(3):398-401.
330. Chung P, Abramowicz J, Edgar D, et al. Acute maternal obstructive renal failure in a twin gestation despite normal physiological pregnancy-induced urinary tract dilation. Am J Perinatol. 1994;11(3): 242-244.
331. Fox J, Katz M, Klein S, et al. Sudden anuria in a pregnant woman with a solitary kidney. Am J Obstet Gynecol. 1978;132(5):583-585.
332. Butler E, Cox S, Eberts E, et al. Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol. 2000;96(5 pt 1):753-756.
333. Fischer MJ. Chronic kidney disease and pregnancy: Maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14(2):132-145.
334. Fischer MJ, Lehnerz SD, Hebert JR, et al. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis. 2004;43(3):415-423.
335. Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49(3): 800-805.
336. Anonymous. Pregnancy and renal disease. Lancet. 1975;2:801-802.
337. Lindheimer MD, Davison JM. Pregnancy and CKD: Any progress? (comment). Am J Kidney Dis. 2007;49(6):729-731.
338. Smith MC, Moran P, Ward MK, et al. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG. 2008;115(1): 109-112.
339. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307(11):652-659.
340. Baylis C. Impact of pregnancy on underlying renal disease. Adv Ren Replace Ther. 2003;10(1): 31-39.
341. Hayslett JP. Interaction of renal disease and pregnancy. Kidney Int. 1984;25(3):579-587.
342. Surian M, Imbasciati E, Cosci P, et al. Glomerular disease and pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron. 1984;36(2): 101-105.
343. Jungers P, Houillier P, Forget D, et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet. 1995;346(8983): 1122-1124.
344. Hou S. Pregnancy in women with chronic renal disease. N Engl J Med. 1985;312(13):836-839.
345. Imbasciati E, Pardi G, Capetta P, et al. Pregnancy in women with chronic renal failure. Am J Nephrol. 1986;6(3):193-198.
346. Cunningham FG, Cox SM, Harstad TW, et al. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol. 1990;163(2):453-459.
347. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4): 226-232.
348. Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: Fetal and maternal outcomes. Am J Kidney Dis. 2007;49(6):753-762.
349. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis. 1999;33(2):235-252.
350. Hayslett JP. Kidney disease and pregnancy. Kidney Int. 1999;25:579.
351. Jungers P, Houillier P, Forget D, et al. Specific controversies concerning the natural history of renal disease in pregnancy. Am J Kidney Dis. 1991;17(2):116-122.
352. Packham DK, North RA, Fairley KF, et al. Primary glomerulonephritis and pregnancy. Q J Med. 1989;71(266):537-553.
353. Vidaeff AC, Yeomans ER, Ramin SM. Pregnancy in women with renal disease. Part I: General principles. Am J Perinatol. 2008;25(7):385-97.
354. Jungers P, Chauveau D, Choukroun G, et al. Pregnancy in women with impaired renal function. Clin Nephrol. 1997;47(5):281-288.
355. Jungers P, Houillier P, Chauveau D, et al. Pregnancy in women with reflux nephropathy. Kidney Int. 1996;50(2):593-599.
356. Trevisan G, Ramos JG, Martins-Costa S, et al. Pregnancy in patients with chronic renal insufficiency at Hospital de Clinicas of Porto Alegre, Brazil. Ren Fail. 2004;26(1): 29-34.
357. Abe S. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy. Clin Nephrol. 1994;41(2):61-64.
358. Bar J, Ben-Rafael Z, Padoa A, et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Nephrol. 2000;53(6): 437-444.
359. Combs CA, Kitzmiller JL. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol. 1991;34(3): 505-515.
360. Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care. 1996;19(10):1067-1074.
361. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol. 1996;87(3):401-409.
362. Gashti CN, Bakris GL. The role of calcium antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens. 2004;13(2):155-161.
363. Bakris GL, Weir MR, Secic M, et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int. 2004;65(6):1991-2002.
364. Khandelwal M, Kumanova M, Gaughan JP, et al. Role of diltiazem in pregnant women with chronic renal disease. J Matern Fetal Neonatal Med. 2002;12(6):408-412.
365. Petri M. The Hopkins Lupus Pregnancy Center: Ten key issues in management. Rheum Dis Clin North Am. 2007;33(2):227-235.
366. Dhar JP, Sokol RJ. Lupus and pregnancy: Complex yet manageable. Clin Med Res. 2006;4(4): 310-321.
367. Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus. 2006;15(3): 148-155.
368. Bobrie G, Liote F, Houillier P, et al. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis. 1987;9(4):339-343.
369. Hayslett JP. Maternal and fetal complications in pregnant women with systemic lupus erythematosus. Am J Kidney Dis. 1991;17(2): 123-126.
370. Vidaeff AC, Yeomans ER, Ramin SM. Pregnancy in women with renal disease. Part II: Specific underlying renal conditions. Am J Perinatol. 2008;25(7):399-405.
371. Jungers P, Chauveau D. Pregnancy in renal disease. Kidney Int. 1997;52(4):871-885.
372. Katzir Z, Rotmensch S, Boaz M, et al. Pregnancy in membranous glomerulonephritis-Course, treatment and outcome. Clin Nephrol. 2004;61(1): 59-62.
373. Chapman AB, Johnson AM, Gabow PA. Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;5(5): 1178-1185.
374. Confortini P, Galanti G, Ancona G, et al. Full term pregnancy and successful delivery in a patient on chronic haemodialysis. Proc Eur Dial Transplant Assoc. 1971;8:74-78.
375. Anonymous. Successful pregnancies in women treated by dialysis and kidney transplantation. Report from the Registration Committee of the European Dialysis and Transplant Association. Br J Obstet Gynaecol. 1980;87(10): 839-845.
376. Hou SH. Pregnancy in women on haemodialysis and peritoneal dialysis. Baillieres Clin Obstet Gynaecol (review). 1994;8(2):481-500.
377. Hou SH. Frequency and outcome of pregnancy in women on dialysis. Am J Kidney Dis. 1994;23(1): 60-63.
378. Bagon JA, Vernaeve H, De Muylder X, et al. Pregnancy and dialysis. Am J Kidney Dis. 1998;31(5): 756-765.
379. Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis. 1998;31(5):766-773.
380. Reddy SS, Holley JL. Management of the pregnant chronic dialysis patient. Adv Chronic Kidney Dis. 2007;14(2):146-155.
381. Holley JL, Reddy SS. Pregnancy in dialysis patients: A review of outcomes, complications, and management (review and 31 references). Semin Dial. 2003;16(5):384-388.
382. Hou S. Modification of dialysis regimens for pregnancy. Int J Artif Organs. 2002;25(9): 823-826S.
383. Eroglu D, Lembet A, Ozdemir FN, et al. Pregnancy during hemodialysis: Perinatal outcome in our cases. Transplant Proc. 2004;36(1):53-55.
384. Chao AS, Huang JY, Lien R, et al. Pregnancy in women who undergo long-term hemodialysis. Am J Obstet Gynecol. 2002;187(1):152-156.
385. Okundaye I, Hou S. Management of pregnancy in women undergoing continuous ambulatory peritoneal dialysis. Adv Perit Dial. 1996;12: 151-155.
386. Davison JM. Dialysis, transplantation, and pregnancy. Am J Kidney Dis. 1991;17(2): 127-132.
387. Muirhead N, Sabharwal AR, Rieder MJ, et al. The outcome of pregnancy following renal transplantation-The experience of a single center. Transplantation. 1992;54(3):429-432.
388. McKay DB, Josephson MA. Pregnancy in recipients of solid organs-effects on mother and child. N Engl J Med. 2006;354(12):1281-1293.
389. Josephson MA, McKay DB. Considerations in the medical management of pregnancy in transplant recipients. Adv Chronic Kidney Dis. 2007;14(2): 156-167.
390. Coscia LA, Constantinescu S, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transplant. 2007: 29-42.
391. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA) (see comment). Lancet. 1999;354(9185):1147-1152.
392. Briggs JD, Jager K. The first year of the new ERA-EDTA Registry. Nephrol Dial Transplant. 2001; 16(6):1130-1131.
393. Sturgiss SN, Davison JM. Effect of pregnancy on the long-term function of renal allografts: An update. Am J Kidney Dis. 1995;26(1): 54-56.
394. Salmela KT, Kyllonen LE, Holmberg C, et al. Impaired renal function after pregnancy in renal transplant recipients. Transplantation. 1993; 56(6):1372-1375.
395. Rahamimov R, Ben-Haroush A, Wittenberg C, et al. Pregnancy in renal transplant recipients: Long-term effect on patient and graft survival. A single-center experience. Transplantation. 2006;81(5):660-664.
396. McKay DB, Josephson MA, Armenti VT, et al. Reproduction and transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant. 2005;5(7):1592-1599.
397. Armenti VT, Constantinescu S, Moritz MJ, et al. Pregnancy after transplantation. Transplant Rev. 2008;22(4):223-240.
398. Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity. 2003;36(1):51-56.